Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended-Release Oxybutynin in the Treatment of Neurogenic Detrusor Overactivity (RONDO)

NCT01796548 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd.,Thailand as lead sponsor.

NCT NCT01796548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01796548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended-Release Oxybutynin in the Treatment of Neurogenic Detrusor Overactivity (RONDO)
Lead sponsor
Janssen-Cilag Ltd.,Thailand
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2008
Completion date
December 31, 2010
Enrollment
17 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

detrusor function, overactive